Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19

A novel coronavirus has emerged in late 2019 capable of causing a severe respiratory disease known as COVID-19. Its pathogenesis appears to be the initiation of an immune response and resulting cytokine storm that damages the healthy lung tissue of the host. Some epidemiological studies found bacill...

Descripción completa

Detalles Bibliográficos
Autores principales: Leeson, Cale E., Ismail, Asmaa, Hashad, Mohamed M., Elmansy, Hazem, Shahrour, Walid, Prowse, Owen, Kotb, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433676/
https://www.ncbi.nlm.nih.gov/pubmed/32838196
http://dx.doi.org/10.1007/s42399-020-00461-3
_version_ 1783572002672476160
author Leeson, Cale E.
Ismail, Asmaa
Hashad, Mohamed M.
Elmansy, Hazem
Shahrour, Walid
Prowse, Owen
Kotb, Ahmed
author_facet Leeson, Cale E.
Ismail, Asmaa
Hashad, Mohamed M.
Elmansy, Hazem
Shahrour, Walid
Prowse, Owen
Kotb, Ahmed
author_sort Leeson, Cale E.
collection PubMed
description A novel coronavirus has emerged in late 2019 capable of causing a severe respiratory disease known as COVID-19. Its pathogenesis appears to be the initiation of an immune response and resulting cytokine storm that damages the healthy lung tissue of the host. Some epidemiological studies found bacillus Calmette-Guérin (BCG) vaccine can help to decrease morbidity and mortality of the viral infection. We aim to review and summarize what is known about COVID-19 and the current implications of intravesical BCG with regard to the disease.
format Online
Article
Text
id pubmed-7433676
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-74336762020-08-18 Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19 Leeson, Cale E. Ismail, Asmaa Hashad, Mohamed M. Elmansy, Hazem Shahrour, Walid Prowse, Owen Kotb, Ahmed SN Compr Clin Med Covid-19 A novel coronavirus has emerged in late 2019 capable of causing a severe respiratory disease known as COVID-19. Its pathogenesis appears to be the initiation of an immune response and resulting cytokine storm that damages the healthy lung tissue of the host. Some epidemiological studies found bacillus Calmette-Guérin (BCG) vaccine can help to decrease morbidity and mortality of the viral infection. We aim to review and summarize what is known about COVID-19 and the current implications of intravesical BCG with regard to the disease. Springer International Publishing 2020-08-18 2020 /pmc/articles/PMC7433676/ /pubmed/32838196 http://dx.doi.org/10.1007/s42399-020-00461-3 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Covid-19
Leeson, Cale E.
Ismail, Asmaa
Hashad, Mohamed M.
Elmansy, Hazem
Shahrour, Walid
Prowse, Owen
Kotb, Ahmed
Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19
title Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19
title_full Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19
title_fullStr Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19
title_full_unstemmed Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19
title_short Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19
title_sort systematic review: safety of intravesical therapy for bladder cancer in the era of covid-19
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433676/
https://www.ncbi.nlm.nih.gov/pubmed/32838196
http://dx.doi.org/10.1007/s42399-020-00461-3
work_keys_str_mv AT leesoncalee systematicreviewsafetyofintravesicaltherapyforbladdercancerintheeraofcovid19
AT ismailasmaa systematicreviewsafetyofintravesicaltherapyforbladdercancerintheeraofcovid19
AT hashadmohamedm systematicreviewsafetyofintravesicaltherapyforbladdercancerintheeraofcovid19
AT elmansyhazem systematicreviewsafetyofintravesicaltherapyforbladdercancerintheeraofcovid19
AT shahrourwalid systematicreviewsafetyofintravesicaltherapyforbladdercancerintheeraofcovid19
AT prowseowen systematicreviewsafetyofintravesicaltherapyforbladdercancerintheeraofcovid19
AT kotbahmed systematicreviewsafetyofintravesicaltherapyforbladdercancerintheeraofcovid19

Ejemplares similares